UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 9, 2003 CONCENTRAX, INC. ---------------- (Exact name of registrant as specified in its charter) Nevada 0 32459 65-0887846 - ---------------------------- ----------- ------------------- (State or other jurisdiction Commission (IRS Employer of Incorporation) File Number Identification No.) 2400 Augusta Place, Suite 425 Houston 77075 ---------------------------------------- ---------- (Address of principal executive offices) (Zip Code) Registrant's Telephone Number, including area code: (888) 481-2207 (Former name or former address, if changed since last report.) FORM 8-K ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS. See Item 5. ITEM 5. OTHER EVENTS. a) On November 12, 2003, Concentrax and Concentrax Europe, Ltd. signed a termination agreement ending their Strategic Alliance and Exclusive Distribution Agreement. As a result of that termination, 2,500,000 escrowed shares of the Company's Common Stock are being returned to the Company. b) On November 13, 2003, Concentrax and Mercados Americas signed a termination agreement ending their Marketing and Exclusive Distribution Agreement. c) On October 9, 2003 the United States Patent and Trademark Office granted a patent Mark Gifford, which he assigned to Concentrax, Inc., covering "Self monitoring vehicle alert and tracking device system and associated methods." Exhibits: 10.21 Termination Agreement CE 10.22 Termination Agreement MA SIGNATURES ---------- Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Concentrax, Inc. ------------------------- Registrant 11/4/03 -------------------------- ------------ Mark Gifford, President and CEO Date